169
Views
25
CrossRef citations to date
0
Altmetric
Original Research

Daunorubicin-TiO2 nanocomposites as a “smart” pH-responsive drug delivery system

, , &
Pages 235-242 | Published online: 12 Jan 2012

References

  • PetreCEDittmerDPLiposomal daunorubicin as treatment for Kaposi’s sarcomaInt J Nanomedicine20072327728818019828
  • HidakaMYoshidaRSelf-oscillating gel composed of thermosensitive polymer exhibiting higher LCSTJ Control Release2011150217117621130818
  • WuWWChenBAChengJABiocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignanciesInt J Nanomedicine201051079108421170355
  • ZhangDWZhangHNieJYangJSynthesis and self-assembly behavior of pH-responsive amphiphilic copolymers containing ketal functional groupsPolym Int2010597967974
  • XiongXBMaZSLaiRLavasanifarAThe therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicinBiomaterials201031475776819818492
  • ZhangHJChenBAJiangHWangCLWangHPWangXMA strategy for ZnO nanorod mediated multi-mode cancer treatmentBiomaterials20113271906191421145104
  • BarickKCNigamSBahadurDNanoscale assembly of mesoporous ZnO: a potential drug carrierJ Mater Chem2010203164466452
  • SongMZhangRYDaiYYThe in vitro inhibition of multidrug resistance by combined nanoparticulate titanium dioxide and UV irradiationBiomaterials200627234230423816600364
  • LiQNWangXMLuXHThe incorporation of daunorubicin in cancer cells through the use of titanium dioxide whiskersBiomaterials200930274708471519500830
  • ZhangHJJiangHWangHPZhaoJChenBAWangXMUltrasound mediated drug-loaded nanoparticles crossing cell membranes as a new strategy to reverse cancer multidrug resistanceJ Nanosci Nanotechnol20111131834184021449318
  • BarefordLASwaanPWEndocytic mechanisms for targeted drug deliveryAdv Drug Delivery Rev2007598748758
  • GilliesERGoodwinAPFréchetJMAcetals as pH-sensitive linkages for drug deliveryBioconjug Chem20041561254126315546191
  • LuongAIssarapanichkitTKongSDFongRYangJpH-sensitive, N-ethoxybenzylimidazole (NEBI) bifunctional crosslinkers enable triggered release of therapeutics from drug delivery carriersOrg Biomol Chem20108225105510920820656
  • YooHSLeeKHOhJEParkTGIn vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release200068341943110974396
  • PrabaharanMGrailerJJPillaSSteeberDAGongSQAmphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug deliveryBiomaterials200930295757576619643472
  • GhavamiSHashemiMAndeSRApoptosis and cancer: mutations within caspase genesJ Med Genet200946849751019505876